These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 9153277)

  • 1. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
    Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
    J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
    da Silva MB; Herion F; Raskinet R; David JL; Gustin P; Dessy C; Lekeux P
    Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
    Foster AP; Lees P; Andrews MJ; Cunningham FM
    Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H; Imanishi N; Natsume Y; Morooka S
    Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
    Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.
    Frostegård J; Huang YH; Rönnelid J; Schäfer-Elinder L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):963-8. PubMed ID: 9157962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell adhesion by membrane-bound paf-acether.
    Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
    Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood.
    Chan WP; Levy JV
    Prostaglandins; 1991 Oct; 42(4):337-42. PubMed ID: 1665568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia.
    Wang Y; Adair CD; Weeks JW; Lewis DF; Alexander JS
    J Soc Gynecol Investig; 1999; 6(3):136-41. PubMed ID: 10376269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
    Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.